Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Feb;177(3):469-489.
doi: 10.1111/bph.14524. Epub 2018 Dec 2.

Histamine pharmacology: from Sir Henry Dale to the 21st century

Affiliations
Review

Histamine pharmacology: from Sir Henry Dale to the 21st century

Ekaterini Tiligada et al. Br J Pharmacol. 2020 Feb.

Abstract

Histamine has been one of the most studied substances in medicine, playing a major role in diverse (patho)physiological processes. It elicits its multifaceted modulatory functions by activating four types of GPCRs, designated as H1-4 . Despite the heterogeneity and the complexity of histamine receptor pharmacology, many discoveries over the past 100 years resulted in the development of H1 antihistamines and H2 -targeting 'blockbuster' therapeutics for the management of allergies and gastrointestinal disorders respectively. Recently, a first-in-class H3 inverse agonist was approved for the treatment of narcolepsy, whereas H4 antagonists are under clinical evaluation for their potential therapeutic exploitation in immune-related diseases. This review critically presents the past successes and drawbacks in histamine research, complemented by the modern conceptual innovations in molecular and receptor pharmacology. It targets both young and experienced researchers in an ongoing effort to stimulate novel insights for the dissection of the translational potential of histamine pharmacology. LINKED ARTICLES: This article is part of a themed section on New Uses for 21st Century. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.3/issuetoc.

PubMed Disclaimer

Conflict of interest statement

E.T. is currently president and M.E. is past president of the EHRS.

Figures

Figure 1
Figure 1
Timeline of the major achievements in histamine research and in the therapeutic exploitation of histamine receptor (H1–H4) ligands. HDC, histidine decarboxylase; HNMT, histamine N‐methyltransferase.
Figure 2
Figure 2
Overview of the main functions of the histamine receptors. Histamine is formed in various cell types (rectangular box) and orchestrates numerous actions via binding to four receptor types, designated as H1–H4. Gas, Gai/o, Gaq/11: G protein Ga subunits.
Figure 3
Figure 3
Historical features of the EHRS portraying the Honorary and Late Honorary Members and illustrating in chronological order the members who served as Secretary‐General and President of the Society since 1972. Honorary membership is the highest award of the EHRS, only given to very special people who contributed significantly to the Society and histamine research (EHRS, 2018). The members' place of work is shown in brackets. The EHRS logo is presented in the bottom left hand corner.

Similar articles

Cited by

References

    1. Ackermann D (1910). Über den bakteriellen Abbau des Histidin. Hoppe‐Seylers. Z Physiol Chem 65: 504–510.
    1. Acosta‐Andrade C, Lambertos A, Urdiales JL, Sánchez‐Jiménez F, Peñafiel R, Fajardo I (2016). A novel role for antizyme inhibitor 2 as a regulator of serotonin and histamine biosynthesis and content in mouse mast cells. Amino Acids 48: 2411–2421. - PubMed
    1. Akdis CA, Simons FE (2006). Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533: 69–76. - PubMed
    1. Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Marrion NV, Peters JA et al (2017a). The Concise Guide to PHARMACOLOGY 2017/18: G protein‐coupled receptors. Br J Pharmacol 174: S17–S129. - PMC - PubMed
    1. Alexander SPH, Fabbro D, Kelly E, Marrion NV, Peters JA, Faccenda E et al (2017b). The Concise Guide to PHARMACOLOGY 2017/18: Catalytic receptors. Br J Pharmacol 174: S225–S271. - PMC - PubMed